These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 35318738

  • 1. Effect of rosemary leaf powder with weight loss diet on lipid profile, glycemic status, and liver enzymes in patients with nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
    Akbari S, Sohouli MH, Ebrahimzadeh S, Ghanaei FM, Hosseini AF, Aryaeian N.
    Phytother Res; 2022 May; 36(5):2186-2196. PubMed ID: 35318738
    [Abstract] [Full Text] [Related]

  • 2. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
    Darvish Damavandi R, Shidfar F, Najafi M, Janani L, Masoodi M, Akbari-Fakhrabadi M, Dehnad A.
    Phytother Res; 2021 Jun; 35(6):3145-3156. PubMed ID: 33880813
    [Abstract] [Full Text] [Related]

  • 3. The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double-blind clinical trial.
    Goodarzi R, Jafarirad S, Mohammadtaghvaei N, Dastoorpoor M, Alavinejad P.
    Phytother Res; 2021 Oct; 35(10):5871-5882. PubMed ID: 34498307
    [Abstract] [Full Text] [Related]

  • 4. Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: A randomized double-blind clinical trial.
    Rostamizadeh P, Asl SMKH, Far ZG, Ahmadijoo P, Mahmudiono T, Bokov DO, Alsaikhan F, Jannat B, Mazloom Z.
    Phytother Res; 2022 Oct; 36(10):3949-3956. PubMed ID: 35785498
    [Abstract] [Full Text] [Related]

  • 5. The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease.
    Karandish M, Tamimi M, Shayesteh AA, Haghighizadeh MH, Jalali MT.
    J Res Med Sci; 2013 Jul; 18(7):573-9. PubMed ID: 24516489
    [Abstract] [Full Text] [Related]

  • 6. Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers.
    Climax J, Newsome PN, Hamza M, Weissbach M, Coughlan D, Sattar N, McGuire DK, Bhatt DL.
    J Am Heart Assoc; 2020 Aug 18; 9(16):e016334. PubMed ID: 32779505
    [Abstract] [Full Text] [Related]

  • 7. Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial.
    Behrouz V, Aryaeian N, Zahedi MJ, Jazayeri S.
    J Food Sci; 2020 Oct 18; 85(10):3611-3617. PubMed ID: 32885440
    [Abstract] [Full Text] [Related]

  • 8. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
    Lorvand Amiri H, Agah S, Mousavi SN, Hosseini AF, Shidfar F.
    Arch Iran Med; 2016 Sep 18; 19(9):631-8. PubMed ID: 27631178
    [Abstract] [Full Text] [Related]

  • 9. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F, Farrokhzad A, Tamizifar B, Tarrahi MJ, Entezari MH.
    Phytother Res; 2021 Jan 18; 35(1):477-485. PubMed ID: 32909326
    [Abstract] [Full Text] [Related]

  • 10. A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.
    Zhang PW, Chen FX, Li D, Ling WH, Guo HH.
    Medicine (Baltimore); 2015 May 18; 94(20):e758. PubMed ID: 25997043
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Asghari S, Asghari-Jafarabadi M, Somi MH, Ghavami SM, Rafraf M.
    J Am Coll Nutr; 2018 May 18; 37(3):223-233. PubMed ID: 29313746
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial.
    Musazadeh V, Dehghan P, Khoshbaten M.
    Eur J Gastroenterol Hepatol; 2022 May 01; 34(5):537-545. PubMed ID: 35421019
    [Abstract] [Full Text] [Related]

  • 13. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F, Rashidkhani B, Hekmatdoost A.
    Nutr Res; 2014 Feb 01; 34(2):143-8. PubMed ID: 24461315
    [Abstract] [Full Text] [Related]

  • 14. Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial.
    Gawrieh S, Noureddin M, Loo N, Mohseni R, Awasty V, Cusi K, Kowdley KV, Lai M, Schiff E, Parmar D, Patel P, Chalasani N.
    Hepatology; 2021 Oct 01; 74(4):1809-1824. PubMed ID: 33811367
    [Abstract] [Full Text] [Related]

  • 15. Effects of Cornus mas L. on anthropometric and biochemical parameters among metabolic associated fatty liver disease patients: Randomized clinical trial.
    Bayram HM, Iliaz R, Gunes FE.
    J Ethnopharmacol; 2024 Jan 10; 318(Pt B):117068. PubMed ID: 37611681
    [Abstract] [Full Text] [Related]

  • 16. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Chen S, Zhao X, Ran L, Wan J, Wang X, Qin Y, Shu F, Gao Y, Yuan L, Zhang Q, Mi M.
    Dig Liver Dis; 2015 Mar 10; 47(3):226-32. PubMed ID: 25577300
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
    Hadi A, Mohammadi H, Miraghajani M, Ghaedi E.
    Crit Rev Food Sci Nutr; 2019 Mar 10; 59(15):2494-2505. PubMed ID: 29584449
    [Abstract] [Full Text] [Related]

  • 18. The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial.
    Vahedi H, Atefi M, Entezari MH, Hassanzadeh A.
    Trials; 2022 Jul 08; 23(1):551. PubMed ID: 35804451
    [Abstract] [Full Text] [Related]

  • 19. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM, Mei L, Huang H, Cao SF, Zhao RH, Zheng PY.
    Zhonghua Gan Zang Bing Za Zhi; 2019 May 20; 27(5):369-375. PubMed ID: 31177662
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
    Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, Adorini L, Sciacca CI, Clopton P, Castelloe E, Dillon P, Pruzanski M, Shapiro D.
    Gastroenterology; 2013 Sep 20; 145(3):574-82.e1. PubMed ID: 23727264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.